CVS Follows Walgreens Down Pathway of Least Resistance

The pharmacy giant has postponed plans to sell Pathway's consumer genetic-testing kits in its stores beginning in August until the test vendor squares its regulatory issues with the FDA.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.